Levofloxacin based regimens for the eradication of Helicobacter pylori.
about
Optimum duration of regimens for Helicobacter pylori eradicationEfficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication.Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial.Second-line rescue therapy of helicobacter pylori infection.Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.Efficacy of 14-d vs 7-d moxifloxacin-based triple regimens for second-line Helicobacter pylori eradication.Eradication of Helicobacter pylori: recent advances in treatment.Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line.Rifaximin Plus Levofloxacin-Based Rescue Regimen for the Eradication of Helicobacter pylori.Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis.Levofloxacin, Metronidazole, and Lansoprazole Triple Therapy Compared to Quadruple Therapy as a Second-Line Treatment of Helicobacter pylori Infection in Korea."Rescue" regimens after Helicobacter pylori treatment failure.Effect of fluoroquinolone resistance on 14-day levofloxacin triple and triple plus bismuth quadruple therapy.Levofloxacin-based first-line therapy versus standard first-line therapy for Helicobacter pylori eradication: meta-analysis of randomized controlled trials.Levofloxacin and proton pump inhibitor-based triple therapy versus standard triple first-line therapy for Helicobacter pylori eradication.Emerging therapies for the treatment of Helicobacter pylori infections.Rapid detection of point mutations in the gyrA gene of Helicobacter pylori conferring resistance to ciprofloxacin by a fluorescence resonance energy transfer-based real-time PCR approach.Should quinolones come first in Helicobacter pylori therapy?Rescue Therapy for Helicobacter pylori Infection 2012.Comparison of the once-daily levofloxacin-containing triple therapy with the twice-daily standard triple therapy for first-line Helicobacter pylori eradication: a prospective randomised study.Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial.Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'.Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial.Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial.Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection.A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses.
P2860
Q24201841-E90DA04A-3A92-4283-B4F2-FD5190C9E43BQ33452908-28614F37-576A-4FC5-9412-8DF1F4E6E1D5Q33843119-B121335C-0EB6-4BF1-80FC-ED85B9DCF39DQ34409114-06ED0FBA-A745-4A49-BA9E-6A3FB975DD38Q34570815-870C6E7F-BE23-4205-A64F-101EDCBF896AQ35594239-7743A628-3672-402B-A167-0944F48FAA66Q36191284-881F7A08-0520-42FF-B269-CA2596D8C9B5Q36357419-ECB96830-04E6-4381-B225-1125F1CF19C5Q36385174-E6B6E92C-8C64-4796-8CBF-970D373DEFABQ36423165-60A6B41E-0534-4FFD-84B5-426D3D7D3073Q37046537-46217A62-D2A0-4594-9FF9-35DE2CD0CBE1Q37273653-6AB65FCE-D70E-488F-ACDD-7ADF652F0E43Q37682593-114474D4-6242-4984-A271-A2A89F078646Q38182087-2E090AEC-A6E5-4927-81DE-90F089DE3D2FQ38200052-11FDE82D-AED2-4B3B-8065-A7C2C4F7D805Q38424698-4D3969EA-692A-4929-A237-5D41500EE9B7Q40512028-68744326-0D10-441E-974D-94C3999D2E02Q41807465-9D43072F-B06C-443C-88DB-EB89DBE69AA8Q42129420-FAD7EC77-E19F-4155-A4A9-25300749BAC5Q42905753-1EF58CB1-4D33-4B07-B24B-A76B1BE604D0Q43531758-AD71F268-90AE-4B27-8B8F-E119BB9D4B84Q44581549-C0142FE5-15FA-4CBA-AD24-C9665E486F42Q44611988-73CC83CA-73AE-47D3-868B-D344DEED95DDQ45166053-2281400B-169D-476D-AB6C-AEEEBF610562Q46099612-BE26957F-D44F-4AEE-A91A-B9C3F7212427Q46480398-CB37543D-2758-4E59-85B9-ECDBD8973EC0Q46552854-23B0D8A4-F665-4A57-A67E-F5EAC08221B1
P2860
Levofloxacin based regimens for the eradication of Helicobacter pylori.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Levofloxacin based regimens for the eradication of Helicobacter pylori.
@en
Levofloxacin based regimens for the eradication of Helicobacter pylori.
@nl
type
label
Levofloxacin based regimens for the eradication of Helicobacter pylori.
@en
Levofloxacin based regimens for the eradication of Helicobacter pylori.
@nl
prefLabel
Levofloxacin based regimens for the eradication of Helicobacter pylori.
@en
Levofloxacin based regimens for the eradication of Helicobacter pylori.
@nl
P2093
P1476
Levofloxacin based regimens for the eradication of Helicobacter pylori.
@en
P2093
Alessandro Armuzzi
Antonio Gasbarrini
Enrico C Nista
Filippo Cremonini
Francesco Bartolozzi
Giovanni Cammarota
Luca Santarelli
Marcello Candelli
Maria Assunta Zocco
Simona Di Caro
P304
P356
10.1097/00042737-200212000-00004
P577
2002-12-01T00:00:00Z